1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Giant Cell Tumor of Bone: new trials by email Literature Review of Giant Cell Tumor of Bone trials Research Report on Giant Cell Tumor of Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery Indocyanine Green - Giant Cell Tumor of Bone | Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 40 | 2026-01-02 | 2026-01-05 |
| Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone XGEVA® - Giant Cell Tumor of Bone | Phase 4 | Active not recruiting | Amgen | 36 | 2023-08-17 | 2025-10-01 |
| Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 Denosumab - Giant Cell Tumor of Bone | Phase 4 | Completed | Amgen | 85 | 2017-11-13 | 2024-05-20 |
Giant Cell Tumors (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Bone Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3)
Denosumab (2) · Indocyanine Green (1)
Amgen (2) · Shanghai Jiao Tong University Affiliated Sixth People's Hospital (1)
China (2) · Australia (1) · France (1) · Italy (1) · Poland (1) · Spain (1) · Sweden (1) · Taiwan (1) · United Kingdom (1) · United States (1)
PMID 17013643, PMID 21613624, PMID 31188797, PMID 32224746, PMID 33094400, PMID 33214476, PMID 33754215, PMID 37121582, PMID 37121591, PMID 37178368
2017 (1)